Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003
Published on 04/17/2024 at 07:02, updated on 04/17/2024 at 07:13
Share
Share

Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0500 CAD | +42.86% |
|
-.--% | +25.00% |
Published on 04/17/2024 at 07:02, updated on 04/17/2024 at 07:13
Select your edition
All financial news and data tailored to specific country editions